Gossamer Bio

Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).

  • About
    • The Gossamer Thread
    • Management
    • Board of Directors
  • Pipeline
    • Pipeline Overview
    • Posters and Publications
  • Patients
    • Patients Overview
    • Expanded Access Policy
  • News
  • Get In Touch
    • Locations
    • Contact Us
    • Sponsorship Disclosures
  • Work at Gossamer
    • our benefits
    • career opportunities

Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).

PROSERA clinical trial: NCT05934526

Learn more about the study

© Gossamer Bio | 2024 | Privacy Statement

Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).

PROSERA clinical trial: NCT05934526

Learn more about the study

MENU
  • The Gossamer Thread
  • Management
  • Board of Directors
  • Investors
    • overview
    • news
    • events/presentations
      • events
      • presentations
    • filings
    • governance
      • overview
      • committee composition
      • board of directors
      • management
    • stock
      • stock quote & chart
      • analyst coverage
    • info
      • faqs
      • contact ir
      • email alerts
  • Pipeline
    • Pipeline Overview
    • Posters and Publications
  • Patients
    • Patients Overview
    • Expanded Access Policy
  • News
  • Get In Touch
    • Locations
    • Contact Us
    • Sponsorship Disclosures
  • Work at Gossamer
    • our benefits
    • career opportunities
  • Follow Us